Cusumano Andrea, Ross Robin, Falsini Benedetto, Lombardo Marco
Macula & Genoma Foundation, Rome, Italy.
Department of Experimental Medicine, Ophthalmology Unit, University of Rome Tor Vergata, Rome, Italy.
Ther Adv Ophthalmol. 2025 Jan 16;17:25158414241311078. doi: 10.1177/25158414241311078. eCollection 2025 Jan-Dec.
Diabetic retinopathy and retinal vein occlusion represent two prevalent vision-threatening retinal diseases. Retinal laser therapy still plays an important role in treating these conditions, but its successful administration often requires referral to specialized centers and retina experts. It is, therefore, essential to develop a new treatment methodology that enables patients to benefit from the expertise of specialists from reference centers. For this purpose, we investigated the feasibility of teleguided photocoagulation conducted across continents to determine if different ophthalmologists can consensually devise and safely execute treatment plans remotely. Two patients from Italy (Europe) with diabetic retinopathy and one from Arizona (USA) with central retinal vein occlusion underwent retinal photocoagulation using Navilas 577s with remote teleguidance from the corresponding continental counterpart. The process included remote planning and execution, supported by an audio connection for real-time communication. Teletreatment success criteria included treatment plan completion, patient tolerance, remote connection stability, and technical quality. All treatments have been successfully performed with accurate spot application and no technical issues. Follow-ups at three weeks confirmed positive outcomes for each patient. Remote teleguided retinal photocoagulation appears feasible, offering a promising tool for global collaborations in retina care and potential benefits to regions with limited access to expert supervision.
糖尿病性视网膜病变和视网膜静脉阻塞是两种常见的威胁视力的视网膜疾病。视网膜激光治疗在治疗这些疾病方面仍发挥着重要作用,但其成功实施通常需要转诊至专业中心并由视网膜专家进行操作。因此,开发一种新的治疗方法以使患者能够受益于参考中心专家的专业知识至关重要。为此,我们研究了跨大陆进行远程引导光凝治疗的可行性,以确定不同的眼科医生是否能够协商制定并安全地远程执行治疗计划。两名来自意大利(欧洲)的糖尿病性视网膜病变患者和一名来自亚利桑那州(美国)的视网膜中央静脉阻塞患者,在来自相应大陆地区的同行的远程引导下,使用Navilas 577s进行了视网膜光凝治疗。该过程包括远程规划和执行,并通过音频连接支持实时通信。远程治疗成功标准包括治疗计划完成情况、患者耐受性、远程连接稳定性和技术质量。所有治疗均已成功完成,光斑应用准确,且无技术问题。三周后的随访证实每位患者均取得了积极的治疗效果。远程引导视网膜光凝治疗似乎是可行的,为视网膜护理领域的全球合作提供了一个有前景的工具,并可能为难以获得专家监督的地区带来潜在益处。